Bowel cancer screening across England is identifying roughly 100 cases of the disease every week, according to annual figures published by NHS England. The data, which covers the period from April 2024 to March 2025, has prompted health officials to draw attention to a persistent gap in participation among people in their 50s.
Uptake Among Younger Eligible Adults
Of the age groups invited to take part in the programme, those in their mid-50s showed comparatively lower engagement. NHS England's figures indicate that just 56.2% of 54-year-olds returned their screening kits during the reporting year — meaning nearly one in two people in that age bracket did not complete the test.
The bowel cancer screening programme in England uses a home testing kit, typically a faecal immunochemical test (FIT), which checks for traces of blood in a stool sample. Kits are sent by post to eligible individuals, who return them by mail for laboratory analysis. The process requires no clinic visit and can be completed at home.
Why the Detection Rate Matters
The figure of approximately 100 cancers detected per week through screening underscores the programme's capacity to identify disease at an early or pre-symptomatic stage. Bowel cancer, also known as colorectal cancer, is among the most commonly diagnosed cancers in the United Kingdom. Early-stage detection is generally associated with a broader range of treatment options and improved outcomes, though the NHS England announcement did not provide a breakdown of staging data for screen-detected cases.
The weekly detection figure also reflects the scale at which the programme operates. Across a full year, that rate would correspond to more than 5,000 cases identified through screening alone — a substantial proportion of the total bowel cancer burden.
The Participation Gap in the 50s Age Group
NHS England's appeal specifically targets people in their 50s, the age group that was most recently incorporated into the programme following a lowering of the screening eligibility age. Previously, routine invitations were sent from age 60; the extension to include those in their 50s was intended to capture cancers and pre-cancerous polyps at an earlier point in life.
The lower participation rate among this newer cohort may reflect several factors, including reduced familiarity with the programme, less established habits around health screening, or simply a perception that bowel cancer is predominantly a condition affecting older adults. NHS England's figures do not elaborate on the reasons behind the uptake gap, but the disparity with older age groups is notable.
What the Figures Do Not Show
The published data, as summarised in NHS England's announcement, does not detail overall programme uptake across all age groups, nor does it specify how the 56.2% participation rate among 54-year-olds compares numerically with rates for those in their 60s or 70s. The figures also do not distinguish between first-time participants and those returning kits as part of routine re-invitation cycles.
No information was provided on the proportion of screen-detected cancers that were identified at an early versus advanced stage, or on the outcomes for individuals whose results prompted further investigation.
Context Within Broader Screening Policy
The NHS bowel cancer screening programme has been running in England since 2006 and has undergone several expansions and refinements since its introduction. The shift to the FIT kit from an earlier guaiac-based test was intended to improve sensitivity and encourage higher return rates. Whether the current participation figures represent an improvement, a plateau, or a decline relative to previous years was not addressed in the NHS England release covering the 2024–25 period.
The annual figures serve as a marker of how effectively the programme is reaching its target population — and the 56.2% return rate among 54-year-olds suggests that a substantial portion of those newly eligible for screening are not yet engaging with it.